Delcath Systems, Inc. (DCTH)

Delcath is now showing real commercial traction: FY2025 revenue climbed to $85.2M (+129% YoY), and the latest quarterly filing reports Q2 2026 revenue of $29.1M. The balance sheet is cash-heavy (~$96M in cash and short-term investments at 6/30/2026) with minimal debt and no explicit going-concern language in recent filings. Profitability remains thin despite high gross margin (~87% TTM), and valuation is demanding on earnings/EBITDA multiples—making the near-term story primarily about sustained adoption and operating leverage.

Recent coverage is strongly positive after Delcath’s Q2 beat and raised full‑year guidance (announced), with follow-on analyst target/estimate increases reinforcing the narrative. Media sentiment is determinately bullish and modestly stronger than the prior 30–90 day baseline, and no confirmed legal/regulatory investigation overhang surfaced.

DCTH trades at 16.17 inside a five-week 15.68-16.78 consolidation that follows a powerful advance from ~9 to the 17.42 high. The intermediate and long-term uptrend is intact: price holds well above the rising SMA50 (14.82) and SMA200 (11.48), and the MACD line remains positive (0.30). Near-term momentum is cooling, however - price sits just under the SMA20 (16.47) and EMA9 (16.21), the MACD histogram is negative (-0.18) as the line rolls over, and ADX has faded to 23.3 from 33 - so this is a range/consolidation setup, not a fresh breakout. RSI 53.75 and Williams %R -61.11 are mid-range/neutral. Volume context is constructive (down-day volume lighter than up-day volume; 20-day average dollar volume ~$6.46M). Chart quality is mixed-bullish: trend structure is strong, momentum is neutral-to-fading, which warrants a score of 3. The tradable expression of this chart is a limit buy at the range floor, not a breakout chase at the top of a fading range.